09 August 2019
Ms. Riina Sikkut
Minister of Health and Labour
Ministry of Social Affairs
Suur-Ameerika 1, 10122 Tallinn
Your Excellency,
Subject: Invitation to the THALIA2019 Forum – An informal forum for EU28 on the migration
of thalassaemia │ Monday, 30 September 2019 │ Brussels, Belgium
On behalf of the Board of Directors of the Thalassaemia International Federation (TIF)1, we have the
pleasure to invite you to the upcoming THALIA2019 Forum, the first informal forum of dialogue aimed
at providing EU Member States with the opportunity to informally exchange views and experiences
on addressing the multifaceted problem of the migration of thalassaemia. Organised in the
framework of THALIA20192 and with support from the International Alliance of Patients'
Organizations (IAPO)3, the upcoming event is scheduled to take place on Monday, 30 September
2019 at 18:30-20:00 in Brussels, Belgium and will be followed by a cocktail dinner. The exact venue
and detailed agenda will be communicated to you in the coming days.
Traditionally an endemic disease of the Mediterranean region, thalassaemia was first addressed in
Cyprus, Greece, Italy and the United Kingdom through the establishment of national control
programmes. In recognition of the efficiency and efficacy of the Cyprus thalassaemia control
programme that brought new births to nearly zero and impressively prolonged the survival and quality
of life of patients, the Thalassaemia International Federation established its headquarters in Nicosia,
Cyprus. The THALIA2019 Forum will thus provide participants with the opportunity to learn from each
other and touch upon a much neglected topic that consists an emerging public health: the rise of
thalassaemia in all EU countries.
THE MIGRATION OF THALASSAEMIA
In the last few years, there has been an acceleration of population movements towards Europe,
brought about by the advent of prolonged civil wars in neighbour countries. This phenomenon has
1
Thalassaemia International Federation (TIF) is the global umbrella organisation of 204 thalassaemia patients’ associations from 62 countries,
across the world. IT works in official collaboration with the WHO and is dedicated to promoting equal access to appropriate care for all patients
with thalassaemia. Its extensive educational programme includes a series of educational publications as well as events aiming to spread
awareness and promote effective control programmes across the world. More information at https://thalassaemia.org.cy/
2
THALIA stands for “THALassaemia In Action”, the title given to the Framework Partnership Agreement (No 785243) concluded between the
Thalassaemia International Federation and the European Commission for the period 2018-2021. More information at
https://thalassaemia.org.cy/thalassaemia-in-action-the-thalia-project/
3
International Alliance of Patients’ Organizations (IAPO) is a global alliance representing patients of all nations across all disease areas and
promoting patient-centred healthcare across the world. It works with communities of patients to get their voices heard by all involved in
healthcare. More information at: https://www.iapo.org.uk/
involved large groups of the involved populations and has added to the numbers of economic
migrations, which have been continuing throughout history. Migrants also carry with them their health
problems, and genetic defects are amongst them.
Nonetheless, the issue of hereditary disorders and birth defects is rarely -if ever- addressed by EU
Member States, as emphasis is primarily given to the state of health of migrants and communicable
diseases. Hereditary disorders, including thalassaemia, sickle cell disease and other
haemoglobinopathies, are chronic, and often lifelong conditions, that require specialised
multidisciplinary care and rehabilitation services with psychosocial support. Although the numbers of
affected individuals may be relatively small, the complexity of services that they require makes
considerable demands on the health services of the host country.
The recent migrations are from countries with a high prevalence of hereditary haemoglobin disorders
(thalassaemia and sickle cell disease) to low prevalence areas of Northern and Western Europe.
More specifically, the indigenous populations of the countries of the Middle East, Asia, as well as
those of the Mediterranean are highly prevalent in thalassaemia, while the populations of African
countries are mostly carriers of sickle cell disease. Hence, migrants originating from these regions
are more likely to be healthy carriers of these disorders or indeed patients.
Given that not only affected patients are increasing but also healthy carriers and that these disorders
follow a Medelian inheritance pattern (i.e. from parents to children), the phenomenon is expected to
greatly affect the future birth incidence of these conditions in Europe. This calls for long term policy
considerations and has urged TIF to create a platform of dialogue for EU Member States, as there
are no formal prevention policies in place in most countries, while specialised clinical care is only
provided in selected centres. Also, there is a general absence of national registries that would allow
for better monitoring, planning and resource management.
THE THALIA2019 INFORMAL FORUM
In this context, and for all the above, TIF and IAPO seek to raise awareness on the migration of
thalassaemia among EU Member States to enable them to address existing issues and get prepared
for future ones. Through the THALIA2019 Forum, EU Member States will be able to learn from each
other’s best practices, experience and expertise by entering into informal policy dialogue. Upon joint
recognition of the problem, formal bilateral or regional collaborations shall be promoted with support
from the Thalassaemia International Federation.
The THALIA2019 Forum will focus on three distinct topics that are impactful on service delivery
planning in the short and long term:
(1) Blood Safety and Adequacy;
(2) Prevention and Screening Practices for Hereditary Genetic Diseases;
(3) Migration and New Health Challenges in the EU.
The anticipated outcome will be a Joint Declaration on the Health of Migrants with Hereditary
Disorders, co-signed by all EU countries following the event, which will outline the collaboration of
Member States on this matter and give more strength and better opportunity for TIF, IAPO and other
relevant stakeholders to fight for better results.
INVITATION
With the present communication, you are cordially invited to participate in the THALIA2019
Forum representing the Government of Estonia.
2|Page
We are looking forward to receiving your response regarding your participation at the aforementioned
informal event at your earliest convenience and no later than 2 September 2019. We remain at
your disposal for any further information and/or clarifications that you may require and hope that this
communication marks a long and fruitful collaboration between your esteemed country and our
Federation.
Thank you in advance for your consideration.
Sincerely yours,
Panos Englezos Dr Androulla Eleftheriou
BSC, MSc, PhD
President, Executive Director,
Thalassaemia International Federation Thalassaemia International Federation
Honorary President, Pancyprian Thalassaemia
Association
3|Page
Saatja: Thalassaemia International Federation - EA <thalassaemia-
[email protected]>
Saadetud: 19.08.2019 10:54
Adressaat: SM Info <
[email protected]>
Teema: INVITATION │ THALIA2019 Forum: The first high-level informal forum
for the migration of thalassaemia │ Monday, 30 September 2019 │ Brussels,
Belgium
Tähtsus: Kõrgeim
Your Excellency,
Please find attached an invitation for the aforementioned event on behalf
of Mr. Panos Englezos, President of the Thalassaemia International
Federation (TIF) and Dr Androulla Eleftheriou, TIF Executive Director.
We remain at your disposal should you need any additional information.
Kind regards,
Eleni Antoniou
Senior Policy Officer
Thalassaemia International FederationPO Box 28807, 2083 Strovolos,
CyprusTel: +357 22 319 129
Direct Line: +357 22 205 847Fax: +357 22 314 552Email:
Subscribe to our
To sign up to TIF e-Academy (e-Courses for Patients and Healthcare
Professionals):